A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age
Clinical trial NCT02839330 · COMPLETED
Trial details
- NCT number
- NCT02839330
- Sponsor
- Seqirus
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-11
- Primary completion
- 2017-10-04
- Enrollment
- 3196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.